Comparative studies on the mechanism of action of ACTH1_39 and ACTH5-24 lcorticotropin-(1-39)-and corticotropin-(5-24)-peptides] on isolated rat adrenal cells were performed. The relationship between stimulated steroidogenesis and cyclic AMP was very different, suggesting that cyclic AMP does not play the same role in mediating the action of the two agonists. Data from three separate experiments showed that the competitive antagonist ACTH6-24 [corticotropin-(6-24)-peptidel had mean inhibitor constants of 13.4 + 3.1 nm against ACTHl-39 and 3.4 +1.0nM against ACTH5-24, indicating that the steroidogenic actions of these two agonists are mediated by two different receptor types. We conclude that there are two possible mechanisms for corticotropin action, only one of which AMP.
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The classical involvement of cyclic AMP (Graham-Smith et al., 1967) in the mechanism of action of ACTH (corticotropin) has recently been questioned. Studies using perfused isolated cat adrenals showed that increases in tissue cyclic AMP alone were not sufficient to elicit steroid release (Carchman et al., 1971) . Hudson & McMartin (1975) investigated the kinetics of steroidogenesis and cyclic AMP accumulation in response to ACTH and concluded that their findings did not support an obligatory role for cyclic AMP as a mediator of ACTH action on the adrenal, a conclusion that has also been reached by other authors (Moyle et al., 1973; Ramachandran & Moyle, 1977) . In isolated adrenal cells increased cyclic AMP concentrations were evident in response to cholera toxin 20min before increased steroidogenesis could be discerned (Palfreyman & Schulster, 1975) (Schwyzer, 1978) , and these aspects of ACTH mechanism of action have been reviewed by Schulster & Schwyzer (1980) . We have now used ACTH and two analogues, ACTH4_24, a full agonist (Seelig et al., 1975) , and ACTH6-24, a competitive inhibitor, to investigate further the role of cyclic AMP in steroidogenesis, and whether or not an alternative mechanism is available for the stimulation of steroidogenesis.
Experimental
Preparation of isolated adrenal cells and assay of steroidogenesis Disaggregated rat adrenal cells were prepared by collagenase digestion and corticosteroids accumulated in cells and medium were measured by the fluorescence method Mackie et al., 1972). 0306-3283/020599-05 $1.50/1 Measurement ofcyclic AMP Radiolabelling in vitro and assay of cyclic AMP were as described by Schulster et al. (1978) Fauchere & Petermann (1978 (Fig. 1) . These data are similar to those from previous studies (Mackie et al., 1972) in which statistically significant increases in cyclic AMP were observed at minimally effective doses of hormone (Schulster et al., 1976) , in a competitive protein-binding assay for cyclic AMP. This conclusion has been confirmed by measurements of intracellular receptor-bound cyclic AMP, which have shown an even closer correlation with steroidogenesis (Podesta et al., 1979) . However, for ACTH524 there is a marked discrepancy between these parameters. It is clearly evident that steroidogenesis is stimulated by several hormone concentrations at which no cyclic AMP increases can be discerned (Fig. 1) , and cyclic AMP accumulation only occurs at a peptide-hormone concentration more than 100-fold higher than that required for stimulation of steroidogenesis. Moreover, steroidogenesis is stimulated half-maximally by 0.1 nM-ACTHl-39, as opposed to IOnM-ACTH5.24 (a 100-fold difference), but for comparable cyclic AMP responses there is a 3000-fold difference in peptide concentration. There is thus a vast discrepancy between the changes in the two parameters elicited by the two analogues. Fig. 1 shows data from two typical experiments, and this discrepancy between the effects of ACTH1-39 and ACTH5_24 has been consistently observed. Ways et al. (1979) reported that the fragment ACTH6-39 competitively inhibits the steroidogenic activity of ACTHI_39. In preliminary experiments (not shown) we have found that the 6-24 fragment of the ACTH molecule is also a potent competitive inhibitor of ACTHl-39' (c) (Fig. 2) . The dose-response curves were shifted progressively to the right, to higher median effective dose (ED50) values of hormone, by increasing concentrations of the inhibitor. The inhibitor constant, Kd, for ACTH6-24 against each of the two agonists was determined by using Schild (1947) (Schulster & Schwyzer, 1980) and have indicated two populations of receptors. However, the physiological significance of these binding components remains unknown. In the present study, ACTH6-24 inhibited to a different extent the actions of ACTH1_39 and ACTH5-249 providing evidence that the steroidogenic action of the two agonists is not mediated through the same population of receptors. This evidence, when considered with the data in Fig. 1 , which indicate that the role played by cyclic AMP in mediating the action of the two agonists is not the same in each case, clearly indicates the complexity of the mechanism of action of ACTH. We propose' that ACTH1I39, the physiological hormone, can act via either of two receptors. Binding to one receptor elicits steroidogenesis through'the involvement of cyclic AMP production; binding to the other receptor elicits steroidogenesis through some other mechanism. The details of this other mechanism are as yet unknown, but one may speculate that it might involve Ca2+ and/or' cyclic GMP and perhaps explain the current controversy regarding the involvement or non-involvement of cyclic GMP in this response (Perchellet et al., 1978; Hayashi et al., 1979) . In this model, ACTH1-39 would tend to, work via cyclic AMP and ACTH 24 would tend to work via the other mechanism. That various hormones and neurotransmitters can act via different receptor mechanisms is well established, and in this respect parallels with the known mechanisms of action of catecholamines on a-andf,-adrenergic receptors may be drawn.
With the classical second-messenger hypothesis increasingly being called into question, this modification of the role of cyclic AMP may be widely applicable to peptide hormones, and perhaps provide an answer for some of the current criticisms raised against the theory.
